Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: rfan Khan / Los Angeles Times via Getty Images

The benefits of the Johnson & Johnson coronavirus vaccine outweigh any potential risks, according to the Centers for Disease Control and Prevention.

The big picture: There have been 7.8 cases of Guillain-Barre syndrome, a rare neurological disorder, per million doses among adults, which is higher than expected in the general population, according to CDC data.

  • By comparison, there has been about one case of Guillain-Barre per million doses for people who received either of the two-dose mRNA vaccines, according to the agency.
  • The data comes a little over a week after the Food and Drug Administration added a warning to the Johnson & Johnson coronavirus vaccine, saying the shot can lead to an increased risk of a rare neurological condition.

Driving the news: Despite the small risk of an adverse reaction to the shot, the Johnson & Johnson vaccine prevents against the vast majority of death and serious illness from coronavirus.

  • "Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA Covid-19 vaccines, far outweighing the risks," CDC researcher Dr. Hannah Rosenblum told the agency's Advisory Committee on Immunization Practices in a meeting on Thursday, per CNN.

Between the lines: The CDC data show that for women ages 18 to 29, the vaccine would prevent 8,900 cases of coronavirus and five COVID-19 deaths and only one GBS case might occur.

  • For men in that age group, 6,600 COVID-19 cases and three COVID-19 deaths would be prevented and only two GBS cases might occur.
  • For every million doses administered among women ages 30 to 49, the data suggest 10,100 COVID-19 cases and 20 COVID-19 deaths could be prevented compared with the risk of about six to seven GBS cases.
  • For men in that age group, 7,600 COVID-19 cases and 25 COVID-19 deaths could be prevented compared with the risk of about seven to eight GBS cases.
  • For every million doses administered among women ages 50 to 64, the data suggest 12,100 COVID-19 cases and 120 COVID-19 deaths could be prevented compared with the risk of seven to eight GBS cases.
  • Among men, the vaccine would prevent about 10,100 Covid-19 cases and 140 Covid-19 deaths and come with the risk of between 14 to 17 GBS cases, according to the CDC data.

Go deeper

Harris gets COVID-19 booster shot

Photo: Andrew Caballero-Reynolds/AFP via Getty Images.

Vice President Kamala Harris received a third shot of the COVID-19 vaccine Saturday, while calling on Americans to get vaccinated to "get through and beyond" the pandemic.

Driving the news: The White House said Harris qualifies for a booster shot due to her job duties that include frequent traveling and interacting with people, AP reports.

Oct 30, 2021 - Health

Over 26K NYC workers remain unvaccinated after Friday deadline

Photo: Michael Nagle/Bloomberg via Getty Images

Over 26,000 New York City municipal workers are unvaccinated after a Friday deadline to have received at least one dose of the COVID-19 vaccine, AP reports.

Driving the news: New York City Mayor Bill de Blasio expanded a COVID-19 vaccine mandate on Oct. 20 that covers all of the city's public employees, including police officers and firefighters. Nearly 46,000 unvaccinated employees needed to receive one dose by Friday.

Oct 31, 2021 - Health

Moderna says FDA needs more time to assess risks of vaccine in teens

Photo: Miyer Juana/Long Visual Press/Universal Images Group via Getty Images

Moderna said Sunday that the Food and Drug Administration (FDA) is delaying a decision on approving the emergency use of the company's coronavirus vaccine for children ages 12 to 17.

Driving the news: The FDA informed Moderna that it is evaluating the risk of myocarditis, a condition affecting the wall of the heart, after vaccination, per the release.